KENTERA patch mat 3.9 mg/24h 8 pce
7680577330026
CH-57733
G04BD04
05.02.0.
1 / 3
google
Details
- Product number
- 5773301
- CPT
- -
- Packaging group
- 8
- Unit
- Pflaster
- Composition
- oxybutyninum 36 mg, triacetinum, 2-ethylhexylis acrylatis et N-vinylpyrrolidoni et hexamethyleneglycoli dimethacrylatis polymerisatum, poly(ethylenis terephthalas) et ethyleni et vinylis acetatis polymerisatum, ad praeparationem pro 39 cm², cum liberatione 3.9 mg/24h.
Articles (1)
Kentera, transdermales Pflaster
Transdermales Pflaster
8
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
36.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 47.65
Specialties list
Yes
Generic
No
SL addition date:
01/08/2007
Authorization holder
Teva Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 57733
- Drug name
- Kentera, transdermales Pflaster
- Galenic form
- TRAP
- ATC Code
- G04BD04
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 23/04/2007
- Authorization expiration date
- 31/12/9999
- IT number
- 05.02.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- KENTERA patch mat 3.9 mg/24h 8 pce
- Description (DE)
- KENTERA Matrixpfl 3.9 mg/24h 8 Stk
- Market launch
- 23/04/2007
- Narcotic (BTM)
- No